• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Clinical Trial Recruitment

ProKidney Taps CVS Health Clinical Trial Services for Precision Recruitment

by Fred Pennic 01/31/2023 Leave a Comment

ProKidney Taps CVS Health Clinical Trail Services for Precision Recruitment

What You Should Know: - CVS Health Clinical Trial Services and late clinical-stage cellular therapeutics company ProKidney Corp. today announced a collaboration to enroll patients with type 2 diabetes and chronic kidney disease into the proact 1 (REGEN-006) Phase 3 clinical trial of REACT®. ProKidney’s lead product candidate, REACT® (REnal Autologous Cell Therapy), is a first-of-its-kind, patented, autologous cellular therapy with the potential to not only slow and stabilize the
Read More

Boosting Clinical Trial Recruitment Requires Humanity – and Technology

by Dr. Chris Fourment, SVP of Clinical Strategy at Iterative Health 01/24/2023 Leave a Comment

Boosting Clinical Trial Recruitment Requires Humanity – and Technology

Clinical trials should be a time of promise for better patient outcomes, as they explore new ways to potentially help patients suffering from a variety of conditions. Instead, this phase of treatment development is often met with exasperation as patients, researchers, and drug developers deal with the many barriers to clinical trial recruitment and access.   There are two central – and intrinsically linked – problems with the current state of clinical trial recruitment in the U.S.:
Read More

C2i Genomics & AstraZeneca Partner to Advance Cancer Therapy

by Syed Hamza Sohail 01/05/2023 Leave a Comment

C2i Genomics & AstraZeneca Team Up to Advance Cancer Therapy

What You Should Know: - C2i Genomics, a cancer intelligence company, today announced a strategic collaboration with AstraZeneca, a global life sciences and pharmaceutical leader.  - The two companies have collaborated to evaluate the potential of whole-genome minimal residual disease (MRD) testing across solid cancers. - Expanding on a completion of AstraZeneca’s accelerator BeyondBio SCALE program for start-ups and successful technology validation, C2i Genomics and AstraZeneca
Read More

Reify Health Secures $220M to Support Clinical Trial Diversity at $4.8B Valuation

by Fred Pennic 04/21/2022 Leave a Comment

Reify Health Secures $220M to Support Clinical Trial Diversity

What You Should Know: - Reify Health, a leading provider of solutions that empower the clinical trial ecosystem, announced a $220M Series D funding round dedicated to improving diversity in clinical research. The investment comes less than a year after its Series C and brings the company's valuation to $4.8B.  - The Series C found was co-led by Altimeter Capital and Coatue, joined by Dragoneer Investment Group and existing investors ICONIQ Growth, Adams Street, and Battery
Read More

THREAD Acquires Clinical Trial Recruitment Solution CureClick

by Health M&A Activity 04/20/2022 Leave a Comment

THREAD Acquires Clinical Trial Recruitment Solution CureClick

What You Should Know: - THREAD, a technology and consulting service provider enabling electronic clinical outcome assessments and decentralized clinical trials has acquired CureClick, which offers the world’s first proprietary crowdsourcing platform designed to accelerate awareness and participation in clinical research. This acquisition follows THREAD’s recent acquisitions of Modus Outcomes and inVibe, positioning THREAD as the industry’s leading
Read More

How Support Automation Enhances Clinical Trial Management

by Fred Pennic 03/03/2022 Leave a Comment

How Support Automation Enhances Clinical Trial Management

The life of a clinical study relies on data from documentation, meetings, emails and calls; all of which can be overwhelming for patients, clinical trial teams and associates. Although mundane, documenting, executing and collecting data is crucial to move a trial from phase to phase. Clinical trial teams face a multitude of competing priorities, from evaluating hundreds of potential patients to maintaining compliance and recording patient progress. No aspect or step can be neglected for a
Read More

Reify Health Secures $220M to Go Beyond Decentralized Clinical Trials

by Jasmine Pennic 08/11/2021 Leave a Comment

Reify Health Secures $220M to Go Beyond Decentralized Clinical Trials

What You Should Know: - Reify Health, a Boston-based company paving the way to faster, predictable, and more accessible clinical trials, today announced it has raised $220M in a Series C funding round led by Coatue Management, joined by ICONIQ Growth and Adams Street Partners, as well as existing investors Sierra Ventures and Battery Ventures. This latest funding brings the company’s valuation to $2.2B. - Reify Health has built a new foundation for how clinical trials are run through its
Read More

Hawthorne Effect Secures $20M to Decentralize Clinical Trials

by Jasmine Pennic 06/09/2021 Leave a Comment

Hawthorne Effect Secures $20M to Decentralize Clinical Trials

What You Should Know: - Hawthorne Effect, a San Francisco-based solution for decentralizing clinical trials, today announced it has raised $20M in Series A funding led by Northpond Ventures with participation from SignalFire and P5 Health Ventures. - Founded in 2015, Hawthrone Effect alleviates key issues related to patient recruitment and retention via its tech-driven platform and expansive network of medical professionals. Hawthrone’s key offerings include: - Hawthorne Cloud: The
Read More

Inovalon Launches FHIR-Based Solution for Health Plan Compliance

by Jasmine Pennic 05/22/2020 Leave a Comment

Big Data Firm Inovalon Files First Digital Health IPO of 2015

What You Should Know: - Inovalon announced the availability of its Cloud-Based “Consumer Health Gateway” Module, alleviating the need for health plans to build their own Patient Access API to comply with the new requirement of the 21st Century Cures Act. - The Consumer Health Gateway is a consumer portal allowing the FHIR®-based exchange of a patient’s claims and clinical data securely with authorized third-party applications. It consists of a robust patient consent and authentication
Read More

SubjectWell Launches Patient Registry of 10k+ Patients for COVID-19 Clinical Trials

by Jasmine Pennic 05/15/2020 Leave a Comment

SubjectWell Launches Patient Registry of 10k+ Patients for COVID-19 Clinical Trials

What You Should Know: - SubjectWell launches a patient registry list of 10,000 individuals in the US interested in participating in COVID-19 clinical trials and research. - The new COVID-19 patient registry will accelerate the patient recruitment process for COVID-19 research, giving researchers access to interested individuals who could randomize for various types of trials, whether they are healthy volunteers with no previous exposure to COVID-19, currently sick with the virus, or who
Read More

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Popular

Survey: Clinician Burnout Is A Public Health Crisis Demanding Urgent Action

17 Execs Share How Health IT Can Address Clinician Burnout, Staffing, & Capacity

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Northwell Health Extends Contract with Allscripts Sunrise Platform Through 2027

Northwell to Deploy Epic Enterprise EHR Platform Across System

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Pfizer Acquires Seagen for $43B to Tackle Cancer

Pfizer Acquires Seagen for $43B to Tackle Cancer

5 Key Trends Driving Purchasing Decisions in Healthcare IT

5 Key Trends Driving Purchasing Decisions in Healthcare IT

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Dr. Arti Masturzo

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |